← Back to headlines
Evercore ISI Initiates Revolution Medicines (RVMD) with Outperform Rating
Evercore ISI has begun coverage of Revolution Medicines (RVMD) with an 'Outperform' rating, indicating a positive recommendation for the stock.
27 Feb, 04:53 — 27 Feb, 04:53
Sources
Showing 1 of 1 sources
